The first six years of the Agile BioFoundry provided the foundation for us to launch into our current phase.
Our FY17-FY22 Impact Report provides a look back and outlines our activities in those first six years, during which we:
- Established routes to metabolic beachhead molecules of interest to industry
- Advanced 15 host organisms
- Harnessed machine learning for bioengineering
- Advanced the biofoundry field through leadership and global collaboration
These achievements, along with several others detailed in the report, have positioned the Agile BioFoundry for our current phase focused on bioprocess commercialization and impact.
Our accomplishments demonstrate the power of public investment in biomanufacturing, and how this can be leveraged to create real-world solutions.
